Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study will include the patients who are Japanese children with bronchial asthma aged 5
years to 15 years old and have completed the Phase III study (Study code: D5254C00769) at
about 29 centres. To investigate the safety of budesonide Turbuhaler® with a daily dose of
100 µg to 800 µg for 54 weeks treatment including the prior 6 weeks Phase III study (Study
D5254C00769, NCT00504062) as compared with conventional therapy in Japanese children with
bronchial asthma in need of inhaled glucocorticosteroid treatment.